The journal retracts the article, “Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding image duplication and the overall reliability of several figures presented in this article.
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board, with input from the Uniformed Services University of the Health Sciences, USA. The investigation confirmed duplications between Figure 4A, ERK1/2 panel [1] and Figure 5D, ERK panel published in [2] and between Figure 5C, ABCG1 panel [1] and Figure 3C, p-STAT 3 panel [3], presenting different experimental conditions and originating from a different authorship group. As a result, the Editorial Board has lost confidence in the integrity of the findings and has decided to retract this article [1] as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 12 March 2025).
This retraction was approved by the Editor-in-Chief of the journal Biomedicines.
A.P., H.T., L.M., Y.C., G.L.M., and K.M.D. agreed to the retraction. The remaining author did not provide a comment on this decision.
References
- Paucarmayta, A.; Taitz, H.; McGlorthan, L.; Casablanca, Y.; Maxwell, G.L.; Darcy, K.M.; Syed, V. RETRACTED: Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. Biomedicines 2020, 8, 73. [Google Scholar] [CrossRef] [PubMed]
- Nokin, M.-J.; Bellier, J.; Durieux, F.; Peulen, O.; Rademaker, G.; Gabriel, M.; Monseur, C.; Charloteaux, B.; Verbeke, L.; van Laere, S.; et al. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Res. 2019, 21, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Lin, S.-Y.; Chang, H.-H.; Lai, Y.-H.; Lin, C.-H.; Chen, M.-H.; Chang, G.-C.; Tsai, M.-F.; Chen, J.J.W. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer. PLoS ONE 2015, 10, e0123305. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).